High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancer

Frank M. Scott, Rama Modali, Teresa A. Lehman, Michael Seddon, Karen Kelly, Edward C. Dempsey, Vincent Wilson, Melvyn S. Tockman, James L. Mulshine

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

A high frequency of K-ras mutations may indicate preneoplastic changes in the bronchial epithelium as a result of genotoxic injury. With the use of sensitive detection techniques, we report a higher prevalence of K-ras mutations in bronchoalveolar lavage than has been reported previously for lung cancer. A PCR/ligase chain reaction technique was used to determine K-ras codon 12 mutations in a group of 52 bronchoalveolar lavage specimens from patients at risk of a second lung cancer. Of the specimens examined, 84% contained at least one mutation in K-ras codon 12, corroborated by an allele-specific hybridization method. These results suggest that point mutations in K-ras codon 12 are widespread in the bronchial epithelium. Based on these preliminary findings, further evaluation of this efficient sensitive assay to monitor K-ras status should be conducted in larger clinical cohorts where clinical outcomes will ultimately be available. Such a trial will define the utility of K-ras codon 12 mutation status as a marker of lung cancer.

Original languageEnglish (US)
Pages (from-to)479-482
Number of pages4
JournalClinical Cancer Research
Volume3
Issue number3
StatePublished - 1997
Externally publishedYes

Fingerprint

Second Primary Neoplasms
Bronchoalveolar Lavage Fluid
Codon
Lung Neoplasms
Mutation
Bronchoalveolar Lavage
Ligase Chain Reaction
Epithelium
Point Mutation
Alleles
Polymerase Chain Reaction
Wounds and Injuries

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Scott, F. M., Modali, R., Lehman, T. A., Seddon, M., Kelly, K., Dempsey, E. C., ... Mulshine, J. L. (1997). High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancer. Clinical Cancer Research, 3(3), 479-482.

High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancer. / Scott, Frank M.; Modali, Rama; Lehman, Teresa A.; Seddon, Michael; Kelly, Karen; Dempsey, Edward C.; Wilson, Vincent; Tockman, Melvyn S.; Mulshine, James L.

In: Clinical Cancer Research, Vol. 3, No. 3, 1997, p. 479-482.

Research output: Contribution to journalArticle

Scott, FM, Modali, R, Lehman, TA, Seddon, M, Kelly, K, Dempsey, EC, Wilson, V, Tockman, MS & Mulshine, JL 1997, 'High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancer', Clinical Cancer Research, vol. 3, no. 3, pp. 479-482.
Scott, Frank M. ; Modali, Rama ; Lehman, Teresa A. ; Seddon, Michael ; Kelly, Karen ; Dempsey, Edward C. ; Wilson, Vincent ; Tockman, Melvyn S. ; Mulshine, James L. / High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancer. In: Clinical Cancer Research. 1997 ; Vol. 3, No. 3. pp. 479-482.
@article{b6e9ad74cff14f3c9aa73d41ec1f5007,
title = "High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancer",
abstract = "A high frequency of K-ras mutations may indicate preneoplastic changes in the bronchial epithelium as a result of genotoxic injury. With the use of sensitive detection techniques, we report a higher prevalence of K-ras mutations in bronchoalveolar lavage than has been reported previously for lung cancer. A PCR/ligase chain reaction technique was used to determine K-ras codon 12 mutations in a group of 52 bronchoalveolar lavage specimens from patients at risk of a second lung cancer. Of the specimens examined, 84{\%} contained at least one mutation in K-ras codon 12, corroborated by an allele-specific hybridization method. These results suggest that point mutations in K-ras codon 12 are widespread in the bronchial epithelium. Based on these preliminary findings, further evaluation of this efficient sensitive assay to monitor K-ras status should be conducted in larger clinical cohorts where clinical outcomes will ultimately be available. Such a trial will define the utility of K-ras codon 12 mutation status as a marker of lung cancer.",
author = "Scott, {Frank M.} and Rama Modali and Lehman, {Teresa A.} and Michael Seddon and Karen Kelly and Dempsey, {Edward C.} and Vincent Wilson and Tockman, {Melvyn S.} and Mulshine, {James L.}",
year = "1997",
language = "English (US)",
volume = "3",
pages = "479--482",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancer

AU - Scott, Frank M.

AU - Modali, Rama

AU - Lehman, Teresa A.

AU - Seddon, Michael

AU - Kelly, Karen

AU - Dempsey, Edward C.

AU - Wilson, Vincent

AU - Tockman, Melvyn S.

AU - Mulshine, James L.

PY - 1997

Y1 - 1997

N2 - A high frequency of K-ras mutations may indicate preneoplastic changes in the bronchial epithelium as a result of genotoxic injury. With the use of sensitive detection techniques, we report a higher prevalence of K-ras mutations in bronchoalveolar lavage than has been reported previously for lung cancer. A PCR/ligase chain reaction technique was used to determine K-ras codon 12 mutations in a group of 52 bronchoalveolar lavage specimens from patients at risk of a second lung cancer. Of the specimens examined, 84% contained at least one mutation in K-ras codon 12, corroborated by an allele-specific hybridization method. These results suggest that point mutations in K-ras codon 12 are widespread in the bronchial epithelium. Based on these preliminary findings, further evaluation of this efficient sensitive assay to monitor K-ras status should be conducted in larger clinical cohorts where clinical outcomes will ultimately be available. Such a trial will define the utility of K-ras codon 12 mutation status as a marker of lung cancer.

AB - A high frequency of K-ras mutations may indicate preneoplastic changes in the bronchial epithelium as a result of genotoxic injury. With the use of sensitive detection techniques, we report a higher prevalence of K-ras mutations in bronchoalveolar lavage than has been reported previously for lung cancer. A PCR/ligase chain reaction technique was used to determine K-ras codon 12 mutations in a group of 52 bronchoalveolar lavage specimens from patients at risk of a second lung cancer. Of the specimens examined, 84% contained at least one mutation in K-ras codon 12, corroborated by an allele-specific hybridization method. These results suggest that point mutations in K-ras codon 12 are widespread in the bronchial epithelium. Based on these preliminary findings, further evaluation of this efficient sensitive assay to monitor K-ras status should be conducted in larger clinical cohorts where clinical outcomes will ultimately be available. Such a trial will define the utility of K-ras codon 12 mutation status as a marker of lung cancer.

UR - http://www.scopus.com/inward/record.url?scp=0030888691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030888691&partnerID=8YFLogxK

M3 - Article

C2 - 9815708

AN - SCOPUS:0030888691

VL - 3

SP - 479

EP - 482

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 3

ER -